APLP2: Amyloid Beta Precursor Like Protein 2
A member of the amyloid precursor protein family involved in synaptic function and Alzheimer's disease-related pathways
Gene Information Card
| Symbol | APLP2 |
|---|---|
| Full Name | Amyloid Beta Precursor Like Protein 2 |
| Gene Type | protein-coding |
| Chromosomal Location | 11q24.3 |
| NCBI Gene ID | 334 ncbi.nlm.nih.gov/gene/334 |
| Ensembl ID | ENSG00000118322 |
| UniProt ID | Q06481 |
| OMIM ID | 104776 |
| HGNC ID | 598 |
| Aliases | APLP2, APPL2, CDEBP, APLP-2 |
Description
APLP2 (Amyloid Beta Precursor Like Protein 2) is a member of the amyloid precursor protein (APP) family, which includes APP and APLP1. It encodes a transmembrane glycoprotein involved in synaptic adhesion, neurite outgrowth, and cell signaling. APLP2 is ubiquitously expressed and plays a role in the regulation of synaptic plasticity and neurogenesis. It is processed by secretases similar to APP, generating soluble fragments that may have neuroprotective functions. Mutations and altered expression of APLP2 have been implicated in Alzheimer's disease and certain cancers.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Alzheimer's disease | APLP2 processing by gamma-secretase produces amyloidogenic fragments; altered expression may contribute to amyloid plaque formation | ClinVar, OMIM |
| Colorectal cancer | Overexpression of APLP2 promotes tumor cell proliferation and migration via MAPK/ERK signaling | COSMIC, PubMed |
| Breast cancer | APLP2 upregulation correlates with poor prognosis and metastasis through interaction with integrins | COSMIC, PubMed |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Brain | 12.5 | Medium |
| Lung | 8.3 | Low |
| Liver | 6.1 | Low |
| Kidney | 9.7 | Low |
| Testis | 15.2 | Medium |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| HEK293 | 10.4 | Embryonic kidney cells |
| SH-SY5Y | 14.1 | Neuroblastoma cells |
| HepG2 | 7.8 | Hepatocellular carcinoma cells |
| MCF7 | 11.2 | Breast cancer cells |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.1234G>A (p.Gly412Arg) | Missense | <0.1% | Altered protein processing; potential loss of function |
| c.567C>T (p.Pro189Leu) | Missense | <0.1% | Unknown functional effect |
| c.890_892del (p.Glu297del) | In-frame deletion | <0.1% | May affect synaptic adhesion |
Mutation functional classification
Loss of Function (LOF)
Rare missense variants (e.g., p.Gly412Arg) may impair protein stability or processing, reducing normal synaptic function.
Gain of Function (GOF)
Overexpression in cancer cells suggests potential gain-of-function in tumorigenesis, but specific activating mutations are not well characterized.
Dominant Negative (DN)
No dominant-negative mutations have been reported for APLP2.
View complete mutation data:
Gene Ontology (GO)
| • synaptic adhesion | • neurite outgrowth |
| • cell adhesion | • protein processing |
| • signal transduction |
Pathways
• Alzheimer's disease - presenilin pathway
• APP processing by gamma-secretase
• Integrin signaling pathway
Protein Summary
APLP2 is a type I transmembrane glycoprotein of 763 amino acids, belonging to the APP family. It contains a large extracellular domain with E1 and E2 subdomains, a Kunitz-type protease inhibitor (KPI) domain, and a short cytoplasmic tail with a YENPTY motif involved in endocytosis and signaling. The protein is cleaved by alpha-, beta-, and gamma-secretases, generating soluble N-terminal fragments and a C-terminal fragment that may be further processed. APLP2 is widely expressed in neural and non-neural tissues, where it mediates cell-cell adhesion, neurite outgrowth, and synaptic plasticity. Its structure and processing are similar to APP, but it lacks the amyloid beta peptide region, thus not directly contributing to amyloid plaque formation.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| APLP2 Knockout HEK293 Cell Line | EDJ-KQ4065 | Human | 334 | Details Get a Quote |
| APLP2 Knockout A-549 Cell Line | EDJ-KQ26434 | Human | 334 | Details Get a Quote |
| APLP2 Knockout HCT 116 Cell Line | EDJ-KQ26435 | Human | 334 | Details Get a Quote |
| APLP2 Knockout HeLa Cell Line | EDJ-KQ26436 | Human | 334 | Details Get a Quote |
Displaying Records 1 To 4 Of 4 Records